-
Lazard Downgrades PDL BioPharma (PDLI) to Hold
-
Lazard Upgrades PDL BioPharma (PDLI) to Buy
-
Notable Analyst Rating Changes 6/13: LCC, CAL, HERO Upgraded; BUD, FNSR, PDLI, ADM Downgraded
-
Lazard Capital Downgrades PDL Biopharma (PDLI) to Hold
